The Enterprise Value as of December 2025 (TTM) for AstraZeneca Pharma India Limited (ASTRAZEN.NS) is 227.02B

According to AstraZeneca Pharma India Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 227.02B. This represents a change of 8.54% compared to the average of 209.16B of the last 4 quarters.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Historical Enterprise Value (quarterly & annually)

How has ASTRAZEN.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of AstraZeneca Pharma India Limited over the last ten years is 72.05B. The current 227.02B Enterprise Value has changed 31.41% with respect to the historical average. Over the past ten years (40 quarters), ASTRAZEN.NS's Enterprise Value was at its highest in in the September 2025 quarter at 223.97B. The Enterprise Value was at its lowest in in the December 2021 quarter at 0.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AstraZeneca Pharma India Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Average Enterprise Value

How has ASTRAZEN.NS Enterprise Value performed in the past?

The current Enterprise Value of AstraZeneca Pharma India Limited (ASTRAZEN.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Enterprise Value vs. Peers

How is ASTRAZEN.NS’s Enterprise Value compared to its peers?

AstraZeneca Pharma India Limited’s Enterprise Value is less than Piramal Enterprises Limited (254.86B), greater than Neuland Laboratories Limited (218.89B), greater than Neuland Laboratories Limited (218.89B), less than Piramal Pharma Limited (281.25B), less than J. B. Chemicals & Pharmaceuticals Limited (285.42B), less than J. B. Chemicals & Pharmaceuticals Limited (285.42B), less than Eris Lifesciences Limited (234.70B), less than Eris Lifesciences Limited (234.70B), less than Wockhardt Limited (243.21B), less than Wockhardt Limited (243.21B),

Build a custom stock screener for AstraZeneca Pharma India Limited (ASTRAZEN.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca Pharma India Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca Pharma India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.